Healx Company

Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.


Technology: Artificial Intelligence, Biopharma, Biotechnology, Health Care, Medical
Industry: End-to-end Drug Development, Drug Repurposing
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2014-01-01
Employees Number: 51-100
Funding Status: Early Stage Venture
Investors Number: 10
Total Funding: 67909855
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-10-16
Last Funding Type: Series B

Visit Website
Register and Claim Ownership